Gamze Nur Öter

Gamze Nur Öter

Auto-generated profile, based on publicly available information

Gamze Nur Öter

Department of Medical Pathology, Faculty of Medicine, Istinye University, Türkiye

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications

11 July 2026 in The Journal of Nutritional Biochemistry
Verified
Journal Article
Closed access
SKSumeyye Koc
Sumeyye Koc
STSude Toydemir
Sude Toydemir
GVGökay Vardar
Gökay Vardar
GÖGamze Nur Öter
Gamze Nur Öter
BYBusra Yusufoglu
Busra Yusufoglu

28 March 2024 in Clinical and Experimental Health Sciences
Verified
Journal Article
Open access
PDF file
FÇFatma Zehra Çağıl
Fatma Zehra Çağıl
KAKoray Ak
Koray Ak
ARAb. Matteen Rafiqi
Ab. Matteen Rafiqi
Ayten SaracogluAyten Saracoglu
Ayten Saracoglu
GÖGamze Nur Öter
Gamze Nur Öter
ŞTŞermin Teti̇k
Şermin Teti̇k
Objective: Acute renal failure (ARF) prevalence is high among patients who undergo cardiopulmonary bypass (CPB), and this condition can only be diagnosed via serum creatinine level (sCr) conventionally within 48 hours. Therefore, we need early novel diagnosis biomarkers to start preventive treatment of ARF. For that reason, we aimed to analyze if plasma miR-21 derived from heart, correlates with kidney- enriched miR-10a during inflammatory IL-6, IL-1β, and TNF-α response in terms of acute renal failure 30 minutes after CPB. Methods: Patients (n=46, Female:8 and Male:38), aged 61.08±9.41, who underwent CPB surgery were included. Blood samples were collected during the pre – and post-CPB (30 minutes after CPB). Demographic data of all cases were collected. Quantification of expression levels of miR-21 and miR-10a was done via quantitative PCR (qPCR). Determination of plasma concentration of relevant cytokines, IL-6, IL-1β, and TNF-α was done via ELISA. Results: The circulating level of miR-21 during post-CPB period (-11.78±6.98) was significantly higher (p≤0.05) than pre-CPB period (-6.55±7.11), but there was no significant change (p>0.05) in the circulating level of miR-10a between pre – (-12.22±3.55) and post-CPB (-11.60±3.36) periods. When we compared the mean ΔΔCt values of miR-21 and miR-10a, downregulation was observed in the expression level of miR-10a (0.62±3.77) whilst the expression level of miR-21 (-5.22±7.25) was upregulated (p≤0.05). The levels of plasma concentration of IL-6 (2.74±2.50 ng/l) and TNF-α (83.63±9.33 ng/l) were increased during post-CPB period (both were ***p

26 September 2025 in Demiroglu Science University Florence Nightingale Journal of Medicine
Verified
Journal Article
Closed access
GÖGamze Nur Öter
Gamze Nur Öter
Objectives: Our purpose was to evaluate the expression of long non-coding RNA (lncRNA) zinc finger E-box binding homeobox 1-antisense 1 (ZEB1-AS1) and the transcription factor ZEB1 in prostate cancer (PCa) cells, and to explore their potential role in tumor aggressiveness and epithelial-mesenchymal transition (EMT) regulation. Materials and methods: PC3, DU145, LNCaP, and PNT1A were cultured under standard conditions. miRNeasy Tissue/Cells Advanced Mini Kit was used to isolate total RNA. RT² First Strand Kit was used to synthesize complementary DNA for lncRNAs, and miRCURY LNA RT Kit for microRNAs (miRNAs). Rotor-Gene Q (Qiagen) system was used to carry out quantitative real-time PCR (qRT-PCR) using SYBR Green chemistry. ZEB1-AS1 and ZEB1 levels were measured in the PCa in vitro model. Results: The qRT-PCR analysis revealed that ZEB1-AS1 and ZEB1 were significantly upregulated in androgen-independent PC3 and DU145 cells compared with PNT1A (p<0.01), while LNCaP showed lower expression levels. Elevated ZEB1-AS1 was linked to higher ZEB1 expression, especially in PC3 cells, indicating EMT activation. Conclusion: Our findings suggest the ZEB1-AS1/ZEB1 axis has a crucial role in PCa progression by promoting EMT and metastatic potential. This regulatory network could act as a possible marker and treatment goal, particularly in aggressive, androgen-independent PCa subtypes.